Navigation Links
BioClinica Releases Integrated Medical Image Management Solution
Date:4/16/2013

NEWTOWN, Pa., April 16, 2013 /PRNewswire/ -- BioClinica®, Inc., a global provider of clinical trial management services, announced today the newest release of WebSend, the company's industry-leading medical image submission technology for clinical trials.

(Logo: http://photos.prnewswire.com/prnh/20130403/PH87647LOGO)

BioClinica WebSend is an electronic data transfer solution that offers significant value over other methods to collect and manage medical images for clinical trials. Investigator sites use WebSend to securely transmit medical images for clinical trials over the internet. Pharmaceutical clinical trial sponsors prefer WebSend to outdated alternatives and courier services because it improves the quality of their trial data, makes clinical imaging data immediately available for review, and reduces costs of conducting an imaging-based clinical trial.

The newest version of WebSend offers many capabilities that improve data quality and reduce cost:

  • Protected Health Information (both meta-data and pixel data) is removed prior to image submission
  • Protocol deviations are fully documented before images leave the investigator site.
  • Both DICOM and non-DICOM image data is supported through one system
  • Browser-based DICOM viewer for both web-submitted and couriered images
  • 100% integration with BioPACS, BioClinica's image management system, which eliminates manual data entry and ensures data quality

"Electronic image submission is the best way to ensure data quality and reduce the cost of imaging-based clinical trials," said Mark Weinstein , CEO of BioClinica, "and WebSend is the clear choice to meet these goals." "When
'/>"/>

SOURCE BioClinica, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
2. HCCS Releases ICD-10 Countdown Clock With Integrated CMS Twitter Tweets
3. eCareSoft Releases eCS Cirrus™
4. AtheroNova Releases 2011 Financial Results
5. Atlanta LASIK Surgeon Dr. Ashraf Releases YouTube Videos Featuring Patient Testimonials and Discussion of Common Eye Treatments
6. ILVO-T&V Belgium Releases Validation Report of the Charm Sciences Beta-lactam and Tetracycline 2-minute Test for Raw Commingled Milk
7. ISPE Releases New Guidance for Designing and Constructing Packaging, Labeling and Warehousing Facilities
8. Happtique Releases Draft App Certification Program Standards For Public Comment
9. ClearCanvas Releases New Workstation Products Designed to Assist With Image Sharing
10. OneMedPlace Releases Update to Research Report on Amarantus Biosciences Focused on New Positive Ischemic Heart Disease Efficacy Data for MANF in Animals
11. Weight Loss: Natural Way To Lose More Weight Than With Diet & Exercise Alone - Consumer Reporter Releases A New Video
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... 2015 , ... Rainbow Scientific, Inc. (RSI), a North American ... BI’s line of human mesenchymal stem cell (hMSC) differentiation media, MSC go ... complete system for multipotency evaluation of hMSCs and reliable induction of hMSCs into ...
(Date:7/28/2015)... ... ... The new Xsample 530 sample changer for vials can be used with Anton ... from less than 12,000 mPas (internal air) up to 36,000 (external air) – and can ... eye about Xsample 530 is its removable magazine, which is easily lifted off its hub ...
(Date:7/28/2015)... , July 21, 2015 ... has announced the addition of the "Analysis ... report to their offering. Globally, flow ... including immuno-phenotyping, cell proliferation, cancer, and stem cells. ... clinical applications primarily because of demand from underdeveloped ...
(Date:7/28/2015)...  Kerastem Technologies announce that the Company has received ... For Biologics Evaluation and Research (CBER) Office of Cellular, ... investigating the safety and feasibility of the Company,s technology ... baldness (androgenic alopecia). The phase II study, ... in Europe and ...
Breaking Biology Technology:Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 2Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 3New Moves in Automatic Sample Handling: Introducing Xsample 530 2Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2Kerastem Receives Conditional Approval from FDA for Alopecia Trial 2
... on March 14 at 8:00 a.m. PDT ... ... Halozyme Therapeutics,Inc. (Nasdaq: HALO ), a biopharmaceutical company developing and,commercializing products ... year ended December 31, 2007., "Our achievements in 2007 have advanced ...
... Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: ANP) announced ... agreement with privately held Rex Medical, LP ("Rex,Medical") ... the,Option(TM) inferior vena cava (IVC) filter, a medical ... cava to prevent pulmonary embolism,(PE)., According to ...
... Calif., March 13 Bionovo, Inc.,(Nasdaq: BNVI ... Ph.D., to,the company,s Board of Directors. Dr. Butler ... and in particular in,advancing cancer drug development and ... have George on board as we move into ...
Cached Biology Technology:Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results 2Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results 3Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results 4Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results 5Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results 6Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results 7Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results 8Angiotech and Rex Medical announce exclusive licensing and distribution agreement for the "Option(TM)" inferior vena cava filter 2Angiotech and Rex Medical announce exclusive licensing and distribution agreement for the "Option(TM)" inferior vena cava filter 3Angiotech and Rex Medical announce exclusive licensing and distribution agreement for the "Option(TM)" inferior vena cava filter 4Angiotech and Rex Medical announce exclusive licensing and distribution agreement for the "Option(TM)" inferior vena cava filter 5Angiotech and Rex Medical announce exclusive licensing and distribution agreement for the "Option(TM)" inferior vena cava filter 6George Butler Joins Bionovo's Board of Directors 2George Butler Joins Bionovo's Board of Directors 3
(Date:7/9/2015)... July 9, 2015  Unchained Labs just can,t ... acquisition of Avid Nano. Avid Nano designs, develops ... systems.    Also today, Unchained Labs ... easiest to use protein sizing system. The pUNk ... protein,s hydrodynamic size, size distribution, aggregation population and ...
(Date:7/8/2015)... , July 8, 2015 Summary ... and the fourth most fatal, with a mortality rate ... poor prognosis of pancreatic cancer patients has highlighted a ... which is not being met by the current market. ... array of products with varying molecule types and mechanisms ...
(Date:7/8/2015)... 2015  Trovagene, Inc. (NASDAQ: TROV ), ... the launch of a study that aims to ... (PCM) technology for predicting response to treatment in ... of the novel immunotherapy agents Yervoy® (ipilumumab), a ... The 50-patient study will be led by researchers ...
Breaking Biology News(10 mins):Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... ice-free region of Antarctica have discovered the last traces ... the interior of the southernmost continent before temperatures began ... abrupt and dramatic climate cooling of 8 degrees Celsius, ... 14 million years ago, forced the extinction of tundra ...
... an Indian open-pit coal mine could be the oldest Asian ... monkeys, apes and humans, say researchers from Duke University and ... square inch in size, the teeth are about 54.5 million ... than modern dwarf lemurs weighing about 2 to 3 ounces. ...
... studies presented at the XVII International AIDS Conference in ... of an impurity called ethyl methanesulfonate (EMS). The ... of the manufacturing of mesylate salts, which are contained ... The studies were designed to determine the impact of ...
Cached Biology News:Antarctic fossils paint a picture of a much warmer continent 2Antarctic fossils paint a picture of a much warmer continent 3Antarctic fossils paint a picture of a much warmer continent 4Antarctic fossils paint a picture of a much warmer continent 5Little teeth suggest big jump in primate timeline 2Landmark studies assess risk of exposure to elevated levels of EMS confirm clear toxicity threshold 2
Rabbit polyclonal to hnRNP-U...
... 3.1.21.1) is a nonspecific endonuclease that degrades ... by hydrolyzing phosphodiester linkages, producing mono and ... group. Ambion's RNase-free DNase I is of ... to degrade DNA in the presence of ...
... Agarose Gel-Digesting Preparation contains a unique β-agarose ... quantitative recovery of intact DNA and RNA ... following electrophoresis in TAE, TBE, MOPS, or ... directly in the TAE, TBE, MOPS, and ...
... in-house demand is causing shortages in your laboratory ... can cause unwanted distractions, problems and delays. ... hard work and endeavour! Bring us your idea ... it internationally. We work under ISO 9001 quality ...
Biology Products: